[1] Diaz-Perez R, Davis JE. Pathophysiological mechanisms for the development of gestational diabetes insipidus. J Clin Invest Stud. 2018;1(2):1-3.
[2] Ananthakrishnan S. Gestational diabetes insipidus: diagnosis and management. Best Practice & Research Clinical Endocrinology & Metabolism. 2020;34(5):101384.
[3] Mohebbati R. Anti-oxidant, anti-apoptotic, and protective effects of myricitrin and its solid lipid nanoparticle on streptozotocin-nicotinamide induced diabetic nephropathy in type 2 diabetic male mice. Iranian Journal of Basic Medical Sciences. 2023;26(7):731.
[4] Sparapani S, Millet-Boureima C, Oliver J, Mu K, Hadavi P, Kalostian T, et al. The biology of vasopressin. Biomedicines. 2021;9(1):89.
[5] Mohebbati R, Hosseini M, Khazaei M, Rad AK, Shafei MN. Involvement of the 5-HT1A receptor of the cuneiform nucleus in the regulation of cardiovascular responses during normal and hemorrhagic conditions. Iranian Journal of Basic Medical Sciences. 2020;23(7):858.
[6] Treschan TA, Peters J, Warltier DC. The vasopressin system: physiology and clinical strategies. The Journal of the American Society of Anesthesiologists. 2006;105(3):599-612.
[7] Alikhani V, Mohebbati R, Hosseini M, Khajavirad A, Shafei MN. Role of the glutamatergic system of ventrolateral periaqueductal gray (vlPAG) in the cardiovascular responses in normal and hemorrhagic conditions in rats. Iranian Journal of Basic Medical Sciences. 2021;24(5):586.
[8] Bankir L, Bichet DG, Morgenthaler NG. Vasopressin: physiology, assessment and osmosensation. Journal of internal medicine. 2017;282(4):284-97.
[9] Frank E, Landgraf R. The vasopressin system—from antidiuresis to psychopathology. European journal of pharmacology. 2008;583(2-3):226-42.
[10] Mosi Alrezaee A, Valizad Hasanloee MA, Kazem Pourazar A, Aslani N. Central Diabetes Insipidus Outcome in Neurosurgical Patients Admitted to Intensive Care. JOURNAL OF IRANIAN SOCIETY ANAESTHESIOLOGY AND INTENSIVE CARE. 2019;2(4):53-61.
[11] Birnbaumer M. Vasopressin receptors. Trends in Endocrinology & Metabolism. 2000;11(10):406-10.
[12] Robertson GL. Diabetes insipidus. Endocrinology and metabolism clinics of North America. 1995;24(3):549-72.
[13] John CA, Day MW. Central neurogenic diabetes insipidus, syndrome of inappropriate secretion of antidiuretic hormone, and cerebral salt-wasting syndrome in traumatic brain injury. Critical care nurse. 2012;32(2):e1-e7.
[14] Chanson P, Salenave S, editors. Treatment of neurogenic diabetes insipidus2011: Elsevier.
[15] Bockenhauer D, Bichet DG. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. Nature Reviews Nephrology. 2015;11(10):576-88.
[16] Perkins RM, Yuan CM, Welch PG. Dipsogenic diabetes insipidus: report of a novel treatment strategy and literature review. Clinical and experimental nephrology. 2006;10:63-7.
[17] Aleksandrov N, Audibert F, Bedard M-J, Mahone M, Goffinet F, Kadoch I-J. Gestational diabetes insipidus: a review of an underdiagnosed condition. Journal of Obstetrics and Gynaecology Canada. 2010;32(3):225-31.
[18] Shah SV, Thakur V. Vasopressinase and diabetes insipidus of pregnancy. Annals of Internal Medicine. 1988;109(5):435-6.
[19] Mutter CM, Smith T, Menze O, Zakharia M, Nguyen H. Diabetes insipidus: pathogenesis, diagnosis, and clinical management. Cureus. 2021;13(2).
[20] R EA, A J. Transient diabetes insipidus as a part clinical presentations of preeclampsia: a case report. Tehran University Medical Journal. 2011;69(4):267-70.
[21] Keypour F, Naghi I. Diabetes Insipidus after normal vaginal delivery: a case report. Tehran University Medical Journal. 2014;72(4):268-72.
[22] Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR. Autoimmune hypophysitis. Endocrine reviews. 2005;26(5):599-614.
[23] Cemeroglu A, Blaivas M, Muraszko K, Robertson P, Vazquez D. Lymphocytic hypophysitis presenting with diabetes insipidus in a 14-year-old girl: case report and review of the literature. European journal of pediatrics. 1997;156(9):684-8.
[24] Scherbaum WA. Autoimmune diabetes insipidus. Handbook of Clinical Neurology. 2021;181:193-204.
[25] Tyagaraj K, Mazur A, Miller A, Feierman D. Management of a Parturient with Preeclampsia and HELLP Syndrome Complicated by Gestational Diabetes Insipidus. Open Journal of Anesthesiology. 2016;6(10):175.
[26] Kondo T, Nakamura M, Kitano S, Kawashima J, Matsumura T, Ohba T, et al. The clinical course and pathophysiological investigation of adolescent gestational diabetes insipidus: a case report. BMC Endocrine Disorders. 2018;18(1):1-8.
[27] Calina D, Docea AO, Golokhvast KS, Sifakis S, Tsatsakis A, Makrigiannakis A. Management of endocrinopathies in pregnancy: a review of current evidence. International Journal of Environmental Research and Public Health. 2019;16(5):781.
[28] Schrier RW. Systemic arterial vasodilation, vasopressin, and vasopressinase in pregnancy. Journal of the American Society of Nephrology. 2010;21(4):570-2.
[29] Larijani B, Tabatabaei O, Soltani A, Taheri E, Pajoohi M, Bastanhagh MH, et al. Comparison of the Effect of Desmopressin(DDAVP) Tablet and Intranasal Spray on the Treatment of Central Diabetes Insipidus. Razi Journal of Medical Sciences. 2004;11(40):289-97.
)